HEADER HORMONE/GROWTH FACTOR 13-AUG-98 1IOH TITLE INSULIN MUTANT A8 HIS,(B1, B10, B16, B27)GLU, DES-B30, NMR, 26 TITLE 2 STRUCTURES COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (INSULIN PRECURSOR); COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: 90-110; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: PROTEIN (INSULIN PRECURSOR); COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: 25-53; COMPND 11 ENGINEERED: YES; COMPND 12 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: PANCREAS; SOURCE 6 EXPRESSION_SYSTEM: SACCHAROMYCES CEREVISIAE; SOURCE 7 EXPRESSION_SYSTEM_COMMON: BAKER'S YEAST; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 4932; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 ORGAN: PANCREAS; SOURCE 14 EXPRESSION_SYSTEM: SACCHAROMYCES CEREVISIAE; SOURCE 15 EXPRESSION_SYSTEM_COMMON: BAKER'S YEAST; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 4932 KEYWDS HORMONE, HUMAN INSULIN MUTANT, MONOMER, NEUTRAL PH, HORMONE-GROWTH KEYWDS 2 FACTOR COMPLEX EXPDTA SOLUTION NMR NUMMDL 26 AUTHOR H.B.OLSEN,S.LUDVIGSEN,N.C.KAARSHOLM REVDAT 5 03-NOV-21 1IOH 1 SEQADV REVDAT 4 29-NOV-17 1IOH 1 REMARK HELIX REVDAT 3 24-FEB-09 1IOH 1 VERSN REVDAT 2 22-DEC-99 1IOH 4 HEADER COMPND REMARK JRNL REVDAT 2 2 4 ATOM SOURCE SEQRES REVDAT 1 13-JAN-99 1IOH 0 JRNL AUTH H.B.OLSEN,S.LUDVIGSEN,N.C.KAARSHOLM JRNL TITL THE RELATIONSHIP BETWEEN INSULIN BIOACTIVITY AND STRUCTURE JRNL TITL 2 IN THE NH2-TERMINAL A-CHAIN HELIX. JRNL REF J.MOL.BIOL. V. 284 477 1998 JRNL REFN ISSN 0022-2836 JRNL PMID 9813131 JRNL DOI 10.1006/JMBI.1998.2175 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1IOH COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB. REMARK 100 THE DEPOSITION ID IS D_1000008159. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 307 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NOESY; COSY; TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AMX600 REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : X-PLOR REMARK 210 METHOD USED : DISTANCE GEOMETRY REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 26 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 11 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 9 -154.74 -147.20 REMARK 500 1 SER A 12 -73.60 -83.43 REMARK 500 1 LEU A 13 -38.92 179.72 REMARK 500 1 SER B 9 -38.51 -147.81 REMARK 500 1 GLU B 21 30.83 -89.24 REMARK 500 1 TYR B 26 77.45 -163.05 REMARK 500 1 GLU B 27 58.19 -150.20 REMARK 500 1 PRO B 28 76.71 -69.10 REMARK 500 2 ILE A 2 -40.59 84.43 REMARK 500 2 SER A 12 -84.59 -117.13 REMARK 500 2 LEU A 13 -35.00 -163.60 REMARK 500 2 TYR A 19 51.42 -95.17 REMARK 500 2 VAL B 2 -33.20 -179.24 REMARK 500 2 ASN B 3 -136.17 -137.98 REMARK 500 2 GLU B 21 20.03 46.29 REMARK 500 2 ARG B 22 -62.65 -150.67 REMARK 500 2 TYR B 26 93.37 -179.27 REMARK 500 2 GLU B 27 72.14 -173.17 REMARK 500 3 ILE A 2 -78.14 -88.21 REMARK 500 3 SER A 9 -146.96 -179.86 REMARK 500 3 CYS A 11 -148.54 -119.70 REMARK 500 3 SER A 12 -109.93 -160.39 REMARK 500 3 LEU A 13 10.67 -148.43 REMARK 500 3 ASN A 18 34.88 -88.91 REMARK 500 3 VAL B 2 176.23 80.10 REMARK 500 3 VAL B 18 -72.70 -54.17 REMARK 500 3 CYS B 19 -70.01 -65.62 REMARK 500 3 GLU B 21 -52.81 83.43 REMARK 500 4 SER A 9 -165.65 179.42 REMARK 500 4 SER A 12 -97.06 -108.45 REMARK 500 4 LEU A 13 -40.67 -151.61 REMARK 500 4 GLN B 4 -42.31 -149.92 REMARK 500 4 HIS B 5 64.46 -159.69 REMARK 500 4 LEU B 6 91.61 -49.87 REMARK 500 4 TYR B 26 -146.49 -118.75 REMARK 500 5 SER A 9 -167.36 -163.77 REMARK 500 5 CYS A 11 -159.36 -64.70 REMARK 500 5 SER A 12 -70.67 -130.61 REMARK 500 5 LEU A 13 -34.28 179.91 REMARK 500 5 GLN B 4 146.79 -170.37 REMARK 500 5 HIS B 5 95.80 -68.16 REMARK 500 5 LEU B 6 102.29 -57.32 REMARK 500 5 VAL B 18 -79.95 -90.04 REMARK 500 5 GLU B 21 -36.45 -29.94 REMARK 500 6 ILE A 2 -35.80 175.17 REMARK 500 6 CYS A 11 -174.57 -66.10 REMARK 500 6 SER A 12 -67.50 -125.04 REMARK 500 6 LEU A 13 -34.90 -177.48 REMARK 500 6 TYR A 19 34.77 -92.15 REMARK 500 6 ASN B 3 -95.53 -151.49 REMARK 500 REMARK 500 THIS ENTRY HAS 219 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 1IOH A 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 1IOH B 1 29 UNP P01308 INS_HUMAN 26 53 SEQADV 1IOH GLU B 1 UNP P01308 PHE 25 ENGINEERED MUTATION SEQADV 1IOH GLU B 10 UNP P01308 HIS 34 ENGINEERED MUTATION SEQADV 1IOH GLU B 16 UNP P01308 TYR 40 ENGINEERED MUTATION SEQADV 1IOH GLU B 27 UNP P01308 THR 51 ENGINEERED MUTATION SEQADV 1IOH HIS A 8 UNP P01308 THR 97 ENGINEERED MUTATION SEQRES 1 A 21 GLY ILE VAL GLU GLN CYS CYS HIS SER ILE CYS SER LEU SEQRES 2 A 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 B 29 GLU VAL ASN GLN HIS LEU CYS GLY SER GLU LEU VAL GLU SEQRES 2 B 29 ALA LEU GLU LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 B 29 GLU PRO LYS HELIX 1 HE1 ILE A 2 CYS A 7 1 6 HELIX 2 HE2 SER A 12 TYR A 19 1 8 HELIX 3 HE3 SER B 9 CYS B 19 1 11 SSBOND 1 CYS A 6 CYS A 11 1555 1555 2.02 SSBOND 2 CYS A 7 CYS B 7 1555 1555 2.02 SSBOND 3 CYS A 20 CYS B 19 1555 1555 2.02 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1